Skip to content

Clinical trials

Completed Phase 2 Non-ST Elevated Myocardial Infarction trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Non-ST Elevated Myocardial Infarction Phase: Phase 2 Status: Completed Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20081
20092
20112
20141
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Ablynx, a Sanofi company1
Anthera Pharmaceuticals1
GlaxoSmithKline1
Ischemix, LLC1
Mayo Clinic1
Oslo University Hospital1
Seoul National University Bundang Hospital1
Sinotau Pharmaceutical Group1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Non-ST Elevated Myocardial Infarction8
Angina, Unstable4
Coronary Artery Disease3
Acute Coronary Syndrome2
Angina, Stable2
Myocardial Ischemia1
Myocardial Reperfusion Injury1
ST Elevation Myocardial Infarction1

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.